期刊
MEDICAL MYCOLOGY
卷 49, 期 -, 页码 S7-S12出版社
OXFORD UNIV PRESS
DOI: 10.3109/13693786.2010.505204
关键词
Aspergillus; clinical risk factors; invasive aspergillosis
Despite improvements in the antifungal armamentarium and diagnostic modalities, invasive aspergillosis (IA) remains an important cause of morbidity and mortality in immunocompromised patients. There is an emergence of non-traditional groups at risk for IA, including intensive care unit (ICU) patients, post-operative patients, those with chronic pulmonary diseases, patients with AIDS and patients on immunomodulating drugs (TNF-alpha inhibitors). Identification of clinical risk factors for IA may help in determining which patients require risk modification and other prevention measures.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据